Home / Events /
Patients with CKD in T2D: What is the evidence of Finerenone with SGLT2is?
Patients with CKD in T2D: What is the evidence of Finerenone with SGLT2is?
5.11.2026 18.00

Online LIVE Webinar to discuss:
Patients with CKD in T2D: What is the evidence of Finerenone with SGLT2is?

Speaker:
Prof Sree Venuthurupalli
FRACP, PhD
Sree is a renal physician with close to 30 years experience in the field of clinical Nephrology.
He completed his PhD with the University of Queensland and is serving as an Associate Professor with the Faculty of Medicine.
Sree is the principal investigator for CKD. QLD, the first state-based registry of chronic kidney disease.
Dr Venuthurupalli has his private clinics located in North Brisbane.

Event Joining Details
5.11.2026 18.00
60
Bayer - Cardio Renal Team
Event organiser
Bayer - Cardio Renal Team
Chao Zhang
0437378405